daunorubicin has been researched along with Leukemia L 1210 in 177 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 140 (79.10) | 18.7374 |
1990's | 28 (15.82) | 18.2507 |
2000's | 7 (3.95) | 29.6817 |
2010's | 2 (1.13) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Henry, DW; Kleid, DG; Kuhlmann, KF; Mosher, CW | 1 |
Fujiwara, AN; Henry, DW; Smith, TH | 2 |
Cory, M; Henry, DW; Lee, WW; Tong, GL | 1 |
Bachur, NR; Hildebrand, RC; Meriwether, WD; Steele, M | 1 |
Atassi, G; Baron, M; Bissery, MC; Cros, S; Gebel-Servolles, P; Giorgi-Renault, S; Lavelle, F; Paoletti, C; Renault, J | 1 |
Berscheid, HG; Böttger, D; Hermentin, P; Hoffmann, D; Kraemer, HP; Sedlacek, HH | 1 |
Hansch, C; Khwaja, TA; Selassie, CD | 1 |
Adams, N; Blake, C; Broadhurst, MJ; Bushnell, DJ; Hartmann, HR; Hassall, CH; Keech, E; Stratton, AR; Thomas, GJ | 1 |
Israel, M; Potti, G | 1 |
Acton, EM; Fujiwara, AN; Mosher, CW; Wu, HY | 1 |
Kuhlmann, KF; Mosher, CW | 1 |
Baurain, R; Deprez-De Campeneere, D; Masquelier, M; Trouet, A | 2 |
Bontemps-Gracz, M; Borowski, E; Dzieduszycka, M; Martelli, S; Stefańska, B; Tarasiuk, J | 1 |
Andrianomenjanahary, S; Bosslet, K; Czech, J; Dong, X; Florent, JC; Gaudel, G; Gerken, M; Gesson, JP; Jacquesy, JC; Koch, M; Michel, S; Mitaku, S; Mondon, M; Monneret, C; Renoux, B; Straub, R; Tillequin, F | 1 |
Lee, RJ; Li, H; Wu, J; Xiong, S; Yu, B | 2 |
Hua, DH; Huang, X; Perchellet, EM; Perchellet, JP; Sperfslage, BJ; Tamura, M; Wang, Y | 1 |
Lin, ZP; Sartorelli, AC; Zeng, H | 1 |
Ferragut, JA; Ferrer-Montiel, A; Garcia-Peñarrubia, P; Martín-Orozco, E | 1 |
Csík, G; Hudecz, F; Kovács, P; Reig, F; Reményi, J | 1 |
Kohn, KW; Pommier, Y; Schwartz, RE; Zwelling, LA | 1 |
Arndt, D; Elbe, B; Fichtner, I; Reszka, R | 3 |
Umezawa, H | 1 |
Kerrigan, D; Minford, J; Nichols, M; Shackney, S; Zwelling, LA | 1 |
Rogers, KE; Tökés, ZA | 1 |
Kataoka, T; Ogihara, K; Sakurai, Y | 1 |
Baurain, R; Trouet, A; Zenebergh, A | 3 |
Dawson, KM | 1 |
Tatsuta, K | 1 |
Schwartz, HS | 2 |
Arnold, W; Henneberger, G; Nowak, C; Tanneberger, S | 1 |
Kerrigan, D; Michaels, S; Zwelling, LA | 1 |
Bachur, NR; Clawson, RE; Cohen, JL; Egorin, MJ; Ross, LA | 2 |
Casazza, AM; Di Marco, A; Giuliani, F; Pratesi, G | 1 |
Burke, PJ; Karp, JE; Vaughan, WP | 1 |
Kouno, K; Matsuzawa, Y; Oki, T; Yoshimoto, A | 1 |
Kinoshita, M; Masuda, T; Takahashi, Y; Takeuchi, T; Tatsuta, K; Umezawa, H | 1 |
Airey, JE; Gillard, JW; Israel, M; Murray, RJ | 1 |
Elrod, DW; Houser, DJ; Richard, FA; Wiley, PF | 1 |
Kerrigan, D; Pommier, Y; Schwartz, R; Zwelling, LA | 1 |
Delmotte, F; Kieda, C; Monsigny, M; Roche, AC | 1 |
Maas, E; Mattern, J; Volm, M | 1 |
Konoshita, M; Naganawa, H; Takahashi, Y; Takeuchi, T; Tatsuta, K; Umezawa, H | 1 |
Fodstad, O; Pihl, A | 1 |
Krueger, WC; Li, LH; McGovren, JP; Merritt, MV; Moscowitz, A; Neta, P; Pschigoda, LM; Schpok, SL | 1 |
Crooke, ST; DuVernay, VH; Pachter, JA | 1 |
Hattori, K; Kitao, T | 2 |
Bachur, NR; Clawson, RE; Egorin, MJ; Ross, LA | 1 |
Egorov, LV; Khanykova, OK; Kuznetsova, TV; Rudneva, NA; Vaĭnberg, IuP | 1 |
Deprez-de Campeneere, D; Trouet, A | 1 |
Bhuyan, BK; Blowers, CL; Crampton, SL; Shugars, KD | 1 |
Matsuzawa, Y; Naganawa, H; Oki, T; Takeuchi, T; Umezawa, H; Yoshimoto, A | 1 |
Aleu, J; Canaves, JM; Castanys, S; Ferragut, JA; Ferrer-Montiel, AV; Gamarro, F; Gonzalez-Ros, JM; Planells-Cases, R; Soto, F | 1 |
Johdo, O; Nishida, H; Okamoto, R; Takeuchi, T; Yoshimoto, A | 1 |
Ali-Osman, F; Ishikawa, T | 1 |
Fujii, S; Johdo, O; Kubo, K; Nishida, H; Okamoto, R; Takeuchi, T; Yoshimoto, A | 2 |
Buquen, JJ; Canitrot, D; Canitrot, Y; Lahmy, S; Lautier, D | 1 |
Iwasaki, H; Kamiya, K; Kawai, Y; Nakamura, T; Takauji, R; Tohyama, K; Ueda, T; Yamauchi, T | 1 |
Chang, MS; Kobayashi, N; Lim, GJ; Takagi, Y; Tsuchiya, T | 1 |
Nakai, K; Takagi, Y; Tsuchiya, T | 1 |
Brantis, CE; Hua, DH; Huang, X; Magill, MJ; Perchellet, EM; Perchellet, JP | 1 |
Courseille, C; Dautant, A; Langlois D'estaintot, B; Mondon, M; Précigoux, G; Saminadin, P | 1 |
Dalke, DM; Hua, DH; Huang, X; Magill, MJ; Perchellet, EM; Perchellet, JP | 1 |
Broggini, M; Damia, G; Geroni, C; Marchini, S; Marsiglio, A; Pennella, G; Ripamonti, M | 1 |
Mihich, E; Orsini, F; Pavelic, Z | 1 |
Colombo, A; di Marco, A; Velcich, A; Zunino, F | 1 |
Cardinali, G; Colombi, A; Lai, V; Rivelli, L | 1 |
Bhuyan, BK; Day, KJ; Fraser, TJ | 1 |
Luini, W; Mantovani, A; Peri, G; Polentarutti, N; Spreafico, F | 1 |
Sheid, B; Sorace, RA | 1 |
Acton, EM; Henry, DW; Tong, GL | 1 |
Elias, F; Henderson, E; Holland, JF; Ohnuma, T | 1 |
Casazza, AM | 1 |
Baurain, R; Deprez-de Campeneere, D; Trouet, A | 1 |
Bourut, C; Dantchev, D; Hayat, M; Mathé, G; Paintrand, M; Slioussartchouk, V | 1 |
Acton, EM; Henry, DW; Mosher, CW; Smith, TH; Tong, GL | 1 |
Berezina, TA; Uteshev, BS | 1 |
Bachur, NR; Clawson, RE; Egorin, MJ; Ross, LA; Schlossberger, NM | 1 |
Baurain, R; Deprez-De Campeneere, D; Huybrechts, M; Trouet, A | 1 |
Huybrechts, M; Symann, M; Troulet, A | 1 |
Kessel, D | 1 |
Ishizuka, M; Kinoshita, M; Masuda, T; Naganawa, H; Takahashi, Y; Takeuchi, T; Tatsuta, K; Umezawa, H | 1 |
Inui, T; Komiyana, T; Matsuzawa, Y; Naganawa, H; Oki, T; Takahashi, Y; Takeuchi, T; Umezawa, H | 1 |
Hirano, S; Hori, S; Inui, T; Ishizuka, M; Oki, T; Shirai, M; Takeuchi, T; Tsukagoshi, S; Umezawa, H | 1 |
Casazza, AM; Dasdia, T; Di Marco, A; Necco, A; Pratesi, G; Rivolta, P; Velcich, A; Zaccara, A; Zunino, F | 1 |
Hattori, K; Kitao, T; Takeshita, M | 1 |
Edelstein, M; Valeriote, F; Vietti, T | 2 |
Casazza, AM; Di Marco, A; Pratesi, G; Soranzo, C | 1 |
Bekesi, JG; Corey, RW; Cuttner, J; Ellison, RR; Glidewell, O; Hoagland, HC; Holland, JF; Rai, K; Schwartz, J; Wallace, HJ; Wiernik, P | 1 |
Goldin, A; Johnson, RK; Ovejera, AA | 1 |
Khanykova, OK; Vinogorova, GF | 1 |
Dombernowsky, P; Nissen, NI | 1 |
Mantovani, A; Spreafico, F; Tagliabue, A; Vecchi, A | 3 |
Bachur, NR; Reich, SD | 1 |
Arcamone, F; Hanessian, S; Penco, S; Redaelli, S | 1 |
Arcamone, F; Bernardi, L; Casazza, AM; Giardino, P; Marco, A; Patelli, B; Pratesi, G; Reggiani, P | 1 |
Frei, E; Israel, M; Modest, EJ | 1 |
Chervinsky, DS; Wang, JJ | 1 |
Connors, TA | 1 |
Chen, JH; Holland, JF; Ohnuma, T | 1 |
Arakawa, M; Shimizu, F | 1 |
Marks, TA; Venditti, JM | 1 |
Johdo, O; Naganawa, H; Okamoto, R; Sawa, T; Takeuchi, T; Tone, H; Yoshimoto, A | 1 |
Johdo, O; Okamoto, R; Takeuchi, T; Tone, H; Yoshimoto, A | 1 |
Delius, M; Gambihler, S | 1 |
Auclair, C; Florent, JC; Guillosson, JJ; Monneret, C; Nafziger, J | 1 |
Capranico, G; Kohn, KW; Orr, A; Pommier, Y | 1 |
Baguley, BC; Brownlee, RT; Cacioli, P; Chandler, CJ; Kyratzis, I; Phillips, DR; Reiss, JA; Scourides, PA | 1 |
Fomicheva, EV; Lazhko, EI; Pomanova, NP; Saburova, TP; Zbarskiĭ, VB | 1 |
Arakawa, M; Ekimoto, H; Nagahata, T; Takahashi, K; Uchida, T | 1 |
Matsuo, K; Sugimoto, Y; Takeda, S; Tsukagoshi, S; Yamada, Y | 1 |
Matsuo, K; Sugimoto, Y; Takeda, S; Toko, T; Tsukagoshi, S; Wierzba, K; Yamada, Y | 1 |
Perez-Soler, R; Priebe, W | 1 |
Akai, S; Honda, T; Kirihara, M; Kita, Y; Mohri, S; Okunaka, R; Sasho, M; Sekihachi, J; Shimooka, K; Tamura, Y | 1 |
Bak, M; Efferth, T; Mattern, J; Volm, M | 1 |
Florent, JC; Genot, A; Monneret, C | 1 |
Komuro, K; Nosaka, C; Park, H; Takagi, Y; Takeuchi, T; Tsuchiya, T; Umezawa, S | 1 |
Kobayashi, N; Komuro, K; Nosaka, C; Takagi, Y; Takeuchi, T; Tsuchiya, T; Umezawa, S | 1 |
Bowen, P; Katz, D; Krishna, G; Singh, Y; Ulrich, L | 1 |
Adams, EG; Bhuyan, BK | 1 |
FitzGerald, GB; Ratliff, J; Wick, MM | 1 |
Ben-Efraim, S; Bizzini, B; Ophir, R; Relyveld, EH | 1 |
Komuro, K; Kunimoto, S; Nosaka, C; Takagi, Y; Takeuchi, T; Tsuchiya, T; Umezawa, H; Umezawa, K; Umezawa, S | 1 |
Borowski, E; Martelli, S; Mazerska, Z; Stefanska, B; Woynarowska, B | 1 |
Duncan, R; Kopecek, J; Kopecková, P; Seymour, LW | 1 |
Bontemps-Gracz, M; Borowski, E; Dzieduszycka, M; Martelli, S; Stefańska, B | 1 |
Duncan, R; Hume, IC; Kopecek, J; Kopecková, P; Lloyd, JB; Strohalm, J | 1 |
Ok, K; Takagi, Y; Tsuchiya, T; Umezawa, H; Umezawa, S | 1 |
Murray, SL; Slater, LM; Stupecky, M; Sweet, P; Wetzel, MW | 1 |
Cable, HC; Duncan, R; Hume, I; Kopecek, J; Kopecková-Rejmanová, P; Lloyd, JB; Pohl, J; Strohalm, J | 1 |
Ando, S; Kagawa, D; Nakamura, T; Sasada, M; Uchino, H; Ueda, T | 1 |
Fizames, C | 1 |
Fujii, S; Ishikura, T; Johdo, O; Kubo, K; Naganawa, H; Sawa, T; Takeuchi, T; Umezawa, H; Yoshimoto, A | 2 |
Beljanski, M; Beljanski, MS | 1 |
Borowski, E; Dzieduszycka, M; Martelli, S; Stefanska, B | 1 |
Arnold, LJ | 1 |
Kraemer, HP; Röthig, HJ; Sedlacek, HH | 1 |
Groth, G; Marquardt, H; Steinheider, G; Westendorf, J | 1 |
Fizames, C; Imbach, JL; Lavelle, F; Lukacs, G; Olesker, A; Ponsinet, G; Thang, TT | 1 |
Egler, KA; Tritton, TR; Wingard, LB | 1 |
Cheng, CC; Zee-Cheng, KY | 1 |
Kann, HE; Kohn, KW | 1 |
Dechambre, RP; Gosse, C; Le Pecq, JB; Morizet, J; Paoletti, C | 1 |
Di Marco, A | 1 |
Ishihara, Y; Kitaura, K; Takahira, H; Watanabe, Y | 1 |
Henry, DW | 1 |
Bazhanov, VS; Shorin, VA | 1 |
Bennett, LR; Byfield, JE; Chan, YM; Lee, YC | 1 |
Hoshino, A; Ogawa, M | 1 |
Frei, E; Goldin, A; Schabel, FM | 1 |
Grindey, GB; Schwartz, HS | 1 |
Woodman, RJ | 1 |
Acton, EM; Fujiwara, AN; Henry, DW | 1 |
Driscoll, JS; Goldin, A; Hazard, GF; Wood, HB | 1 |
Henderson, ES; Serpick, AA | 1 |
Bachur, NR; Meriwether, WD | 1 |
Acton, EM; Henry, DW; Yamamoto, K | 1 |
Chervinsky, DS; Rosen, JM; Wang, JJ | 1 |
Dulmadge, EA; Lloyd, HH; Wilkoff, LJ | 1 |
Zubrod, CG | 1 |
Hayat, M; Mathé, G; Schneider, M; Schwarzenberg, L | 1 |
DiMarco, A; Goldin, A; Howsden, FL; Sandberg, JS | 1 |
Brockman, RW; Lloyd, HH; Mellett, LB; Montgomery, JA; Schabel, FM; Skipper, HE; Wilkoff, LJ | 1 |
3 review(s) available for daunorubicin and Leukemia L 1210
Article | Year |
---|---|
Drugs used in the treatment of cancer.
Topics: Alkylating Agents; Animals; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Binding Sites; Cell Division; Cisplatin; Daunorubicin; DNA; Doxorubicin; Humans; Leukemia L1210; Mice; Microsomes, Liver; Neoplasms; Structure-Activity Relationship | 1975 |
Daunomycin- and adriamycin-N-(2-hydroxypropyl)methacrylamide copolymer conjugates; toxicity reduction by improved drug-delivery.
Topics: Animals; Antineoplastic Agents; Chemical Phenomena; Chemistry; Daunorubicin; Doxorubicin; Drug Carriers; Leukemia L1210; Mice; Polymethacrylic Acids | 1987 |
Some antineoplastic antibiotics.
Topics: Adenocarcinoma; Amino Sugars; Animals; Antibiotics, Antineoplastic; Azaserine; Benzazepines; Bleomycin; Carcinoma, Ehrlich Tumor; Carcinoma, Hepatocellular; Cricetinae; Dactinomycin; Daunorubicin; DNA; Dogs; Glycosides; Haplorhini; Humans; Leukemia L1210; Liver Neoplasms; Lymphoma; Mice; Mitomycins; Naphthacenes; Plicamycin; Pyrroles; Rats; RNA; Sarcoma 180; Streptonigrin; Streptozocin | 1972 |
2 trial(s) available for daunorubicin and Leukemia L 1210
Article | Year |
---|---|
Acute myelocytic leukemia.
Topics: Animals; BCG Vaccine; Cytarabine; Daunorubicin; Drug Therapy, Combination; Humans; Immunotherapy; Leukemia L1210; Leukemia, Myeloid; Mercaptopurine; Mice; Mycobacterium bovis; Neuraminidase; Thioguanine | 1976 |
Aclarubicin: experimental and clinical experience.
Topics: Aclarubicin; Animals; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Colony-Forming Units Assay; Cytarabine; Daunorubicin; Doxorubicin; Humans; Leukemia L1210; Leukemia, Monocytic, Acute; Naphthacenes | 1985 |
172 other study(ies) available for daunorubicin and Leukemia L 1210
Article | Year |
---|---|
2-Deaminoactinomycin D, synthesis and interaction with deoxyribonucleic acid.
Topics: Animals; Antineoplastic Agents; Cells, Cultured; Circular Dichroism; Dactinomycin; Deamination; Depression, Chemical; DNA; DNA, Bacterial; DNA, Circular; DNA, Neoplasm; Escherichia coli; In Vitro Techniques; Leukemia L1210; Leukemia, Experimental; Magnetic Resonance Spectroscopy; Mice; Nucleic Acid Conformation; Nucleic Acid Denaturation; RNA, Neoplasm | 1977 |
Synthesis of daunorubicin analogues with novel 9-acyl substituents.
Topics: Animals; Daunorubicin; DNA; DNA, Neoplasm; Leukemia L1210; Leukemia, Experimental; Mice; RNA, Neoplasm; Structure-Activity Relationship | 1979 |
Adriamycin analogues. 2. Synthesis of 13-deoxyanthracyclines.
Topics: Animals; Daunorubicin; DNA; Doxorubicin; Leukemia L1210; Leukemia, Experimental; Leukemia, Lymphoid; Mice | 1978 |
Antitumor anthracycline antibiotics. Structure-activity and structure-cardiotoxicity relationships of rubidazone analogues.
Topics: Animals; Cells, Cultured; Daunorubicin; DNA, Neoplasm; Electrocardiography; Heart; Kinetics; Leukemia L1210; Leukemia, Experimental; Leukemia, Lymphoid; Mice; Rats; RNA, Neoplasm; Structure-Activity Relationship | 1978 |
Cellular pharmocodynamics of several anthrocycline antibiotics.
Topics: Animals; Cells, Cultured; Daunorubicin; DNA, Neoplasm; Doxorubicin; In Vitro Techniques; Leukemia L1210; Mice; RNA, Neoplasm; Structure-Activity Relationship; Thymidine; Uridine | 1976 |
Heterocyclic quinones. 17. A new in vivo active antineoplastic drug: 6,7-bis(1-aziridinyl)-4-[[3-(N,N-dimethylamino)propyl]amino]-5,8- quinazolinedione.
Topics: Animals; Antineoplastic Agents; Aziridines; Breast Neoplasms; Cell Division; Cell Line; Drug Screening Assays, Antitumor; Female; Humans; Leukemia L1210; Leukemia, Experimental; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Molecular Structure; Neoplasms, Experimental; Quinazolines; Sarcoma, Experimental; Structure-Activity Relationship | 1991 |
Structure-activity relationship of anthracyclines in vitro.
Topics: Animals; Antibiotics, Antineoplastic; Chemical Phenomena; Chemistry, Physical; Colonic Neoplasms; DNA; Humans; Leukemia L1210; Molecular Structure; Neoplasms; Regression Analysis; Structure-Activity Relationship; Tumor Cells, Cultured | 1990 |
Structure-activity relationships of antineoplastic agents in multidrug resistance.
Topics: Animals; Antineoplastic Agents; Cell Line; Cell Survival; Cricetinae; Dactinomycin; Drug Resistance; Leukemia L1210; Mice; Regression Analysis; Structure-Activity Relationship; Tumor Cells, Cultured | 1990 |
Synthesis and antitumor activity of novel 4-demethoxyanthracyclines.
Topics: Animals; Antibiotics, Antineoplastic; Chemical Phenomena; Chemistry; Doxorubicin; Female; Idarubicin; Leukemia L1210; Leukemia P388; Mice; Structure-Activity Relationship | 1990 |
Adriamycin analogues. Preparation and biological evaluation of some N-perfluoroacyl analogues of daunorubicin, adriamycin, and N-(trifluoroacetyl)adriamycin 14-valerate and their 9,10-anhydro derivatives.
Topics: Animals; Antineoplastic Agents; Daunorubicin; Doxorubicin; Leukemia L1210; Leukemia P388; Mice; Molecular Conformation | 1982 |
Enhanced antitumor properties of 3'-(4-morpholinyl) and 3'-(4-methoxy-1-piperidinyl) derivatives of 3'-deaminodaunorubicin.
Topics: Animals; Antibiotics, Antineoplastic; Daunorubicin; DNA, Neoplasm; Leukemia L1210; Leukemia P388; Mice; Structure-Activity Relationship | 1982 |
New dimeric analogues of ethidium; synthesis, interaction with DNA, and antitumor activity.
Topics: Animals; Antineoplastic Agents; Chemical Phenomena; Chemistry; DNA; DNA, Neoplasm; Ethidium; Leukemia L1210; Leukemia P388; Melanoma; Mice; Neoplasms, Experimental; RNA, Neoplasm | 1981 |
Amino acid and dipeptide derivatives of daunorubicin. 2. Cellular pharmacology and antitumor activity on L1210 leukemic cells in vitro and in vivo.
Topics: Animals; Cells, Cultured; Daunorubicin; Leukemia L1210; Mice | 1980 |
6-[(aminoalkyl)amino]-substituted 7H-benzo[e]perimidin-7-ones as novel antineoplastic agents. Synthesis and biological evaluation.
Topics: Animals; Anthraquinones; Antineoplastic Agents; Leukemia L1210; Leukemia P388; Mice; Pyrimidines; Structure-Activity Relationship | 1993 |
Prodrugs of anthracyclines for use in antibody-directed enzyme prodrug therapy.
Topics: Animals; Antibiotics, Antineoplastic; Antibodies, Monoclonal; Carcinoembryonic Antigen; Cell Division; Daunorubicin; Doxorubicin; Drug Screening Assays, Antitumor; Drug Stability; Escherichia coli; Glucuronates; Glucuronidase; Humans; Hydrolysis; Immunoglobulin Fab Fragments; Kinetics; Leukemia L1210; Mice; Prodrugs; Rats; Recombinant Fusion Proteins; Structure-Activity Relationship; Tumor Cells, Cultured | 1998 |
Triggering liposomal drug release with a lysosomotropic agent.
Topics: Animals; Antibiotics, Antineoplastic; Arylsulfonates; Cell Line, Tumor; Chloroquine; Daunorubicin; Female; Folic Acid; Humans; Hydrogen-Ion Concentration; Leukemia L1210; Liposomes; Lysosomes; Mice; Mice, Inbred DBA; Microscopy, Confocal; Neoplasms | 2010 |
Preparation, therapeutic efficacy and intratumoral localization of targeted daunorubicin liposomes conjugating folate-PEG-CHEMS.
Topics: Animals; Cholesterol; Cholesterol Esters; Daunorubicin; Female; Folic Acid; Leukemia L1210; Liposomes; Mice; Mice, Inbred DBA; Polyethylene Glycols | 2011 |
Among substituted 9,10-dihydro-9,10-[1,2]benzenoanthracene-1,4,5,8-tetraones, the lead antitumor triptycene bisquinone TT24 blocks nucleoside transport, induces apoptotic DNA fragmentation and decreases the viability of L1210 leukemic cells in the nanomol
Topics: Animals; Anthraquinones; Antibiotics, Antineoplastic; Antineoplastic Agents; Apoptosis; Bridged-Ring Compounds; Cell Survival; Daunorubicin; DNA Fragmentation; DNA, Neoplasm; Humans; Leukemia L1210; Nucleosides | 2002 |
Resistance to purine and pyrimidine nucleoside and nucleobase analogs by the human MDR1 transfected murine leukemia cell line L1210/VMDRC.06.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line; Cell Survival; Daunorubicin; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Humans; Leukemia L1210; Purine Nucleosides; Pyrimidine Nucleosides; Transfection | 2004 |
Acquisition of multidrug resistance by L1210 leukemia cells decreases their tumorigenicity and enhances their susceptibility to the host immune response.
Topics: Animals; Antibiotics, Antineoplastic; Antigen Presentation; Cell Proliferation; Daunorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; fas Receptor; Female; Gamma Rays; Interferon gamma Receptor; Leukemia L1210; Mice; Mice, Inbred DBA; Receptors, Interferon; Survival Rate | 2005 |
The effect of the structure of branched polypeptide carrier on intracellular delivery of daunomycin.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Animals; Daunorubicin; Drug Carriers; HL-60 Cells; Humans; Intercellular Signaling Peptides and Proteins; Leukemia L1210; Leukemia, Promyelocytic, Acute; Liposomes; Mice; Molecular Structure; Peptides; Proteins; Tumor Cells, Cultured | 2006 |
Formation and rejoining of deoxyribonucleic acid double-strand breaks induced in isolated cell nuclei by antineoplastic intercalating agents.
Topics: Adenosine Triphosphate; Aminoacridines; Amsacrine; Animals; Antineoplastic Agents; Binding Sites; Daunorubicin; DNA; DNA Repair; DNA, Single-Stranded; Ellipticines; Intercalating Agents; Leukemia L1210; Magnesium; Mice; Sodium Chloride; Topoisomerase I Inhibitors | 1984 |
[Liposome encapsulation as a possibility for the improvement of tumor chemotherapy].
Topics: Animals; Daunorubicin; Dose-Response Relationship, Drug; Female; Leukemia L1210; Leukemia, Experimental; Liposomes; Mice; Mice, Inbred Strains; Neoplasm Transplantation; Neoplasms, Experimental; Sarcoma, Experimental | 1981 |
Recent studies on antibiotics and small molecular immunomodulators with potential usefulness in treating lung cancer: Part I - Antitumor antibiotics and their derivatives.
Topics: Aclarubicin; Adjuvants, Immunologic; Animals; Antibiotics, Antineoplastic; Bleomycin; Daunorubicin; Doxorubicin; Humans; Leukemia L1210; Lung; Lung Neoplasms; Mice; Molecular Weight; Naphthacenes; Peplomycin; Structure-Activity Relationship | 1982 |
Enhancement of the DNA breakage and cytotoxic effects of intercalating agents by treatment with sublethal doses of 1-beta-D-arabinofuranosylcytosine or hydroxyurea in L1210 cells.
Topics: Aminoacridines; Amsacrine; Animals; Bleomycin; Cell Survival; Cytarabine; Daunorubicin; DNA, Neoplasm; Doxorubicin; Drug Synergism; Hydroxyurea; Intercalating Agents; Leukemia L1210; Mice | 1984 |
Novel mode of cytotoxicity obtained by coupling inactive anthracycline to a polymer.
Topics: Animals; Antibiotics, Antineoplastic; Daunorubicin; Glutaral; Idarubicin; Leukemia L1210; Microspheres; Polymers | 1984 |
Immunoprophylactic and immunotherapeutic response by concanavalin A-bound tumor vaccine enhanced by chemotherapeutic agents eliminating possible suppressors.
Topics: Animals; Concanavalin A; Cyclophosphamide; Daunorubicin; Drug Administration Schedule; Immunization; Immunotherapy; Leukemia L1210; Male; Mice; Mitomycins; Prognosis; T-Lymphocytes, Regulatory; Vaccines | 1980 |
Cellular pharmacology of detorubicin and doxorubicin in L1210 cells.
Topics: Animals; Antibiotics, Antineoplastic; Cell Nucleus; Cells, Cultured; Daunorubicin; DNA, Neoplasm; Doxorubicin; Hydrolysis; Leukemia L1210; Lysosomes; Mice | 1984 |
Activity of SC33428, a novel bishydrazone-bridged derivative of 4-demethoxydaunorubicin, against experimental tumors in mice.
Topics: Animals; Antineoplastic Agents; Daunorubicin; Doxorubicin; Idarubicin; Leukemia L1210; Leukemia P388; Lung Neoplasms; Melanoma; Mice; Neoplasms, Experimental | 1983 |
[New anthracycline antibiotics and derivatives].
Topics: Aclarubicin; Animals; Anthracyclines; Antibiotics, Antineoplastic; Daunorubicin; Doxorubicin; Leukemia L1210; Mice; Naphthacenes; Structure-Activity Relationship | 1984 |
[Preparation, properties and therapeutic effect of Daunorubicin-containing liposomes].
Topics: Animals; Daunorubicin; Drug Compounding; Leukemia L1210; Liposomes; Mice; Microscopy, Electron | 1983 |
Enhanced antitumor activity of adriamycin in combination with allopurinol.
Topics: Allopurinol; Animals; Antineoplastic Combined Chemotherapy Protocols; Daunorubicin; Doxorubicin; Female; Leukemia L1210; Mice; Mice, Inbred DBA; Oxidation-Reduction; Xanthine Oxidase | 1983 |
[Carminomycin in combination with some cytostatics. 1. Efficacy in leukemia L1210].
Topics: Animals; Antineoplastic Agents; Carubicin; Daunorubicin; Drug Evaluation, Preclinical; Drug Therapy, Combination; Leukemia L1210; Leukocyte Count; Mice | 1983 |
Cytotoxicity and DNA strand breaks by 5-iminodaunorubicin in mouse leukemia L1210 cells: comparison with adriamycin and 4'-(9-acridinylamino)methanesulfon-m-anisidide.
Topics: Aminoacridines; Amsacrine; Animals; Cell Survival; Cells, Cultured; Daunorubicin; DNA; Doxorubicin; Leukemia L1210; Mice | 1982 |
Cytofluorescence localization of anthracycline antibiotics.
Topics: Animals; Antibiotics, Antineoplastic; Cell Nucleus; Cytoplasm; Daunorubicin; Doxorubicin; Fluorescence; Glycosides; Histocytochemistry; Leukemia L1210; Mice; Naphthacenes; Neutrophils; Structure-Activity Relationship | 1980 |
Antileukemic activity of 4-demethoxydaunorubicin in mice.
Topics: Administration, Oral; Animals; Daunorubicin; Doxorubicin; Drug Administration Schedule; Drug Evaluation, Preclinical; Female; Idarubicin; Injections, Intravenous; Leukemia L1210; Leukemia P388; Leukemia, Experimental; Male; Mice | 1980 |
Chemotherapy of leukemia in mice, rats, and humans relating time of humoral stimulation, tumor growth, and clinical response.
Topics: Animals; Cell Division; Cytarabine; Daunorubicin; DNA, Neoplasm; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Leukemia; Leukemia L1210; Leukemia, Experimental; Leukemia, Myeloid, Acute; Mice; Rats | 1981 |
A covalent linkage between daunorubicin and proteins that is stable in serum and reversible by lysosomal hydrolases, as required for a lysosomotropic drug-carrier conjugate: in vitro and in vivo studies.
Topics: Albumins; Animals; Daunorubicin; Leukemia L1210; Lysosomes; Mice; Pharmaceutical Vehicles; Structure-Activity Relationship | 1982 |
Cellular pharmacokinetics of aclacinomycin A in cultured L1210 cells. Comparison with daunorubicin and doxorubicin.
Topics: Aclarubicin; Animals; Antibiotics, Antineoplastic; Cells, Cultured; Chromatography, High Pressure Liquid; Daunorubicin; DNA, Neoplasm; Doxorubicin; Kinetics; Leukemia L1210; Mice; Mice, Inbred DBA; Naphthacenes; Subcellular Fractions | 1982 |
Baumycin analogs isolated from Actinomadura sp.
Topics: Animals; Antibiotics, Antineoplastic; Cells, Cultured; Chemical Phenomena; Chemistry; Daunorubicin; Leukemia L1210; Mice; Nocardiaceae; Soil Microbiology | 1981 |
3'-deamino-3'-morpholino derivatives of daunomycin, adriamycin and carminomycin.
Topics: Animals; Antibiotics, Antineoplastic; Carubicin; Chemical Phenomena; Chemistry; Daunorubicin; DNA, Neoplasm; Doxorubicin; Leukemia L1210; Mice; RNA, Neoplasm | 1982 |
Adriamycin analogues. Novel anomeric ribofuranoside analogues of daunorubicin.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Daunorubicin; DNA; Doxorubicin; Humans; Leukemia L1210; Mice; Structure-Activity Relationship | 1982 |
Structure--activity relationships of nogalamycin analogues.
Topics: Animals; Body Weight; Chemical Phenomena; Chemistry; Daunorubicin; Leukemia L1210; Leukemia P388; Mice; Nogalamycin; Structure-Activity Relationship | 1982 |
The formation and resealing of intercalator-induced DNA strand breaks in isolated L1210 cell nuclei.
Topics: Aminacrine; Animals; Cell Nucleus; Daunorubicin; DNA Repair; Ellipticines; Kinetics; Leukemia L1210; Mice | 1982 |
Preparation and biological properties of a covalent antitumor drug--arm---carrier (DAC conjugate).
Topics: Animals; Carrier Proteins; Daunorubicin; Leukemia L1210; Phytohemagglutinins; Plant Lectins; Solubility; Triticum | 1980 |
In vivo and in vitro detection of induced resistance to daunorubicin in murine leukemia L 1210.
Topics: Animals; Cell Line; Daunorubicin; Dose-Response Relationship, Drug; Drug Resistance; Female; Leukemia L1210; Mice | 1981 |
Synthesis of 4-demethoxy-11-deoxy-analogs of daunomycin and adriamycin.
Topics: Animals; Cell Division; Cells, Cultured; Daunorubicin; DNA, Neoplasm; Doxorubicin; Idarubicin; Leukemia L1210; RNA, Neoplasm; Structure-Activity Relationship | 1980 |
Synergistic effect of ricin in combination with daunorubicin, cis-dichlorodiammineplatinum(II) and vincristine in systemic L1210 leukemia.
Topics: Animals; Cell Division; Cisplatin; Daunorubicin; Drug Evaluation, Preclinical; Drug Synergism; Drug Therapy, Combination; Leukemia L1210; Mice; Ricin; Vincristine | 1982 |
The interaction of nogalamycin and analogs with DNA and other biopolymers.
Topics: Animals; Cattle; Circular Dichroism; Daunorubicin; DNA; Hot Temperature; Leukemia L1210; Mice; Nogalamycin; Poly dA-dT; Polydeoxyribonucleotides; Spectrophotometry, Ultraviolet | 1981 |
Therapeutic evaluation of liposome-encapsulated Daunoblastin in murine tumor models.
Topics: Animals; Daunorubicin; Female; Leukemia L1210; Liposomes; Mice; Neoplasms, Experimental; Sarcoma, Experimental | 1981 |
Molecular pharmacological differences between carminomycin and its analog, carminomycin-11-methyl ether, and adriamycin.
Topics: Animals; Carubicin; Cells, Cultured; Daunorubicin; DNA; DNA, Neoplasm; DNA, Superhelical; Doxorubicin; Leukemia L1210; Liver Neoplasms, Experimental; Mice; Rats; RNA, Neoplasm; Structure-Activity Relationship | 1980 |
Erythrocyte entrapment of daunomycin by amphotericin B without hemolysis.
Topics: Amphotericin B; Animals; Cell Membrane Permeability; Daunorubicin; Drug Therapy, Combination; Erythrocyte Membrane; Erythrocytes; Humans; In Vitro Techniques; Leukemia L1210; Mice; Pharmaceutical Vehicles | 1980 |
Cellular pharmacology of N,N-dimethyl daunorubicin and N,N-dimethyl adriamycin.
Topics: Animals; Cell Nucleus; Cells, Cultured; Daunorubicin; DNA, Neoplasm; Doxorubicin; Leukemia L1210; Leukemia, Experimental; Mice; RNA, Neoplasm; Temperature | 1980 |
[Antileukemic activity of carminomycin complexes with a high-polymer DNA].
Topics: Animals; Carubicin; Cells, Cultured; Daunorubicin; DNA; Drug Combinations; Drug Evaluation, Preclinical; In Vitro Techniques; Leukemia L1210; Leukemia, Experimental; Leukemia, Lymphoid; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Molecular Weight; Neoplasm Transplantation | 1980 |
DNA--anthracycline complexes. I. Toxicity in mice and chemotherapeutic activity against L1210 leukemia of daunorubicin--DNA and adriamycin--DNA.
Topics: Animals; Daunorubicin; DNA; Doxorubicin; Drug Administration Schedule; Female; Lethal Dose 50; Leukemia L1210; Mice; Mice, Inbred DBA | 1980 |
Cell kill kinetics of several nogalamycin analogs and adriamycin for Chinese hamster ovary, L1210 leukemia, and B16 melanoma cells in culture.
Topics: Animals; Cell Survival; Cells, Cultured; Cricetinae; Daunorubicin; Dose-Response Relationship, Drug; Doxorubicin; Female; Kinetics; Leukemia L1210; Melanoma; Mice; Neoplasms, Experimental; Nogalamycin; Ovary | 1981 |
Microbial conversion of epsilon-pyrromycinone and epsilon-isorhodomycinone to 1-hydroxy-13-dihydrodaunomcyin and N-formyl-1-hydroxy-13-dihydrodaunomycin and their bioactivities.
Topics: Animals; Anthracyclines; Anti-Bacterial Agents; Antibiotics, Antineoplastic; Biotransformation; Chemical Phenomena; Chemistry, Physical; Daunorubicin; Leukemia L1210; Mice; Mutagens; Mutation; Naphthacenes; Streptomyces | 1980 |
Possible coexistence of two independent mechanisms contributing to anthracycline resistance in leukaemia P388 cells.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blotting, Northern; Blotting, Western; Carrier Proteins; Daunorubicin; Drug Resistance; Gene Expression Regulation, Neoplastic; Hydrogen-Ion Concentration; Leukemia L1210; Leukemia P388; Membrane Glycoproteins; Mice; Neoplasm Proteins; Tumor Cells, Cultured | 1993 |
Anthracycline metabolites from baumycin-producing Streptomyces sp. D788. III. New anthracycline metabolites produced by blocked mutants 4L-660 and YDK-18.
Topics: Animals; Antibiotics, Antineoplastic; Daunorubicin; Leukemia L1210; Mice; Streptomycin; Tumor Cells, Cultured | 1993 |
Glutathione-associated cis-diamminedichloroplatinum(II) metabolism and ATP-dependent efflux from leukemia cells. Molecular characterization of glutathione-platinum complex and its biological significance.
Topics: Adenosine Triphosphate; Animals; Biological Transport; Cell Membrane; Chloramphenicol O-Acetyltransferase; Chromatography, High Pressure Liquid; Chromatography, Ion Exchange; Cisplatin; Daunorubicin; DNA, Neoplasm; Doxorubicin; Glutathione; Kinetics; Leukemia L1210; Magnetic Resonance Spectroscopy; Mass Spectrometry; Mice; Models, Biological; Organoplatinum Compounds; Protein Biosynthesis; Protein Synthesis Inhibitors; Rabbits; Reticulocytes; Ribonucleotides; RNA, Messenger; Spectrophotometry, Atomic; Spectrophotometry, Ultraviolet; Tumor Cells, Cultured; Verapamil | 1993 |
Anthracycline metabolites from baumycin-producing Streptomyces sp. D788. II. New anthracycline metabolites produced by a blocked mutant strain RPM-5.
Topics: Animals; Antibiotics, Antineoplastic; Carubicin; Daunorubicin; DNA Replication; DNA, Neoplasm; Fermentation; Leukemia L1210; Magnetic Resonance Spectroscopy; Mice; RNA, Neoplasm; Streptomyces; Tumor Cells, Cultured | 1993 |
Functional study of multidrug resistance with fluorescent dyes. Limits of the assay for low levels of resistance and application in clinical samples.
Topics: Animals; Anthracyclines; Benzimidazoles; Cell Survival; Clone Cells; Daunorubicin; Drug Resistance, Multiple; Flow Cytometry; Fluorescent Dyes; Leukemia L1210; Mice; Phenotype; Quantum Theory; Reproducibility of Results; Rhodamine 123; Rhodamines; Sensitivity and Specificity; Tumor Cells, Cultured; Vinblastine | 1996 |
Intracellular pharmacodynamics of ara-C and flowcytometric analysis of cell cycle progression in leukemia chemotherapy.
Topics: Animals; Antimetabolites, Antineoplastic; Apoptosis; Arabinofuranosylcytosine Triphosphate; Biotransformation; Cell Cycle; Cell Survival; Cytarabine; Daunorubicin; DNA, Neoplasm; Flow Cytometry; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; HL-60 Cells; Humans; Kinetics; Leukemia L1210; Mercaptopurine; Mice; Tumor Cells, Cultured | 1997 |
Synthesis and antitumor activity of 7-O-(2,6-dideoxy-2-fluoro-alpha-L-talopyranosyl) daunomycinone derivatives modified at C-3' or C-4'.
Topics: Animals; Antibiotics, Antineoplastic; Cell Division; Daunorubicin; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Leukemia L1210; Leukemia P388; Mice; Neoplasm Transplantation; Structure-Activity Relationship; Tumor Cells, Cultured | 1998 |
Synthesis and antitumor activity of 7-O-[2,6-dideoxy-2-fluoro-5-C-(trifluoromethyl)-alpha-L-talopyranosyl]- daunomycinone and -adriamycinone.
Topics: Animals; Antibiotics, Antineoplastic; Daunorubicin; Doxorubicin; Drug Screening Assays, Antitumor; Leukemia L1210; Mice; Molecular Structure; Structure-Activity Relationship | 1999 |
Triptycenes: a novel synthetic class of bifunctional anticancer drugs that inhibit nucleoside transport, induce DNA cleavage and decrease the viability of leukemic cells in the nanomolar range in vitro.
Topics: Animals; Antineoplastic Agents; Biological Transport; Bridged-Ring Compounds; Cell Survival; Daunorubicin; DNA, Neoplasm; Dose-Response Relationship, Drug; Leukemia L1210; Mice; Mitosis; Nucleosides; Quinones; Time Factors; Tumor Cells, Cultured | 1999 |
Release of the cyano moiety in the crystal structure of N-cyanomethyl-N-(2-methoxyethyl)-daunomycin complexed with d(CGATCG).
Topics: Animals; Antibiotics, Antineoplastic; Crystallography, X-Ray; Cyanides; Daunorubicin; DNA; Doxorubicin; Inhibitory Concentration 50; Leukemia L1210; Models, Molecular; Nucleic Acid Conformation | 2000 |
1,4-Anthraquinone: an anticancer drug that blocks nucleoside transport, inhibits macromolecule synthesis, induces DNA fragmentation, and decreases the growth and viability of L1210 leukemic cells in the same nanomolar range as daunorubicin in vitro.
Topics: Animals; Anthraquinones; Antibiotics, Antineoplastic; Biological Transport; Cell Survival; Daunorubicin; DNA Fragmentation; DNA, Neoplasm; Dose-Response Relationship, Drug; In Vitro Techniques; Leukemia L1210; Mitosis; Mitotic Index; Neoplasm Proteins; Nucleosides; RNA, Neoplasm; Tumor Cells, Cultured | 2000 |
4-Demethoxy-3'-deamino-3'-aziridinyl-4'-methylsulphonyl-daunorubicin (PNU-159548), a novel anticancer agent active against tumor cell lines with different resistance mechanisms.
Topics: Animals; Antibiotics, Antineoplastic; CHO Cells; Cricetinae; Daunorubicin; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Female; Humans; Inhibitory Concentration 50; Leukemia L1210; Leukemia P388; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred DBA; Tumor Cells, Cultured | 2001 |
Increased primary cell-mediated immunity in culture subsequent to adriamycin or daunorubicin treatment of spleen donor mice.
Topics: Animals; Antigens, Neoplasm; Cell Adhesion; Cell Separation; Cells, Cultured; Cytotoxicity Tests, Immunologic; Daunorubicin; Doxorubicin; Epitopes; Immunity, Cellular; In Vitro Techniques; Leukemia L1210; Leukemia, Experimental; Macrophages; Mast-Cell Sarcoma; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred DBA; Neoplasms, Experimental; Spleen; Thymoma; Time Factors | 1977 |
Absence of anthracycline-induced degradation of nuclear DNA in Ehrlich ascites tumour cells.
Topics: Animals; Anthracenes; Antibiotics, Antineoplastic; Bleomycin; Carcinoma, Ehrlich Tumor; Cell Nucleus; Centrifugation, Density Gradient; Daunorubicin; DNA, Neoplasm; Doxorubicin; Female; Leukemia L1210; Mice; Neoplasm Proteins; Procarbazine | 1979 |
[Experimental studies on the cytotoxic effects of adriamycin and daunomycin used alone and in combination (author's transl)].
Topics: Animals; Blood; Blood Cell Count; Daunorubicin; Doxorubicin; Drug Combinations; Hematocrit; Hemoglobins; Leukemia L1210; Mice | 1978 |
Cell proliferation kinetics and drug sensitivity of exponential and stationary populations of cultured L1210 cells.
Topics: Amino Acids; Animals; Antineoplastic Agents; Carmustine; Cell Division; Cell Survival; Cells, Cultured; Culture Media; Cytarabine; Dactinomycin; Daunorubicin; DNA, Neoplasm; Doxorubicin; Glucose; Hydroxyurea; Kinetics; Leukemia L1210; Lomustine; Streptozocin; Thymidine; Vincristine | 1977 |
Role of host defense merchanisms in the antitumor activity of adriamycin and daunomycin in mice.
Topics: Animals; Dacarbazine; Daunorubicin; Doxorubicin; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Leukemia L1210; Leukemia, Experimental; Lymphoma; Macrophages; Male; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Neoplasms, Experimental | 1979 |
Cytotoxic effects of the lysosomotropic agents DNA-ellipticine, DNA-daunorubicin, and DNA-ellipticine:daunorubicin on L1210 leukemia cells.
Topics: Alkaloids; Animals; Antineoplastic Agents; Cell Membrane; Cell Survival; Cells, Cultured; Daunorubicin; DNA; Drug Stability; Ellipticines; Leukemia L1210; Lysosomes; Mice; Time Factors | 1979 |
5-Iminodaunorubicin. Reduced cardiotoxic properties in an antitumor anthracycline.
Topics: Animals; Daunorubicin; DNA; DNA, Neoplasm; Heart Diseases; Leukemia L1210; Mice; Mutagens; Neoplasm Transplantation; Neoplasms, Experimental; Rats; RNA, Neoplasm | 1979 |
Pharmacological and therapeutic efficacy of rubidazone in mice. Comparison with daunomycin and adriamycin.
Topics: Animals; Daunorubicin; Doxorubicin; Leukemia L1210; Mice; Spectrometry, Fluorescence; Tissue Distribution | 1979 |
Experimental evaluation of anthracycline analogs.
Topics: Animals; Antibiotics, Antineoplastic; Daunorubicin; Disease Models, Animal; Doxorubicin; Drug Administration Schedule; Drug Evaluation, Preclinical; Glycosides; Heart; HeLa Cells; Leukemia L1210; Leukemia, Experimental; Mice; Naphthacenes; Neoplasms, Experimental; Sarcoma, Experimental | 1979 |
Pharmacokinetic, toxicologic, and chemotherapeutic properties of detorubicin in mice: a comparative study with daunorubicin and adriamycin.
Topics: Animals; Chemical Phenomena; Chemistry; Daunorubicin; Doxorubicin; Female; Leukemia L1210; Mice; Mice, Inbred DBA | 1979 |
Electron microscopic studies of the heart and light microscopic studies of the skin after treatment of golden hamsters with adriamycin, detorubicin, AD-32, and aclacinomycin.
Topics: Aclarubicin; Animals; Antibiotics, Antineoplastic; Cricetinae; Daunorubicin; Doxorubicin; Drug Administration Schedule; Heart; Leukemia L1210; Mesocricetus; Microscopy, Electron; Myocardium; Naphthacenes; Skin | 1979 |
Cellular pharmacology of 7(R)-O-methylnogarol: a new anticancer agent.
Topics: Animals; Cell Nucleus; Daunorubicin; Humans; In Vitro Techniques; Leukemia L1210; Leukemia, Experimental; Macromolecular Substances; Mice; Microscopy, Fluorescence; Naphthacenes; Neutrophils; Nogalamycin; Spectrometry, Fluorescence | 1979 |
7-(Aminoethyl) ether and thioether of daunomycinone.
Topics: Animals; Chemical Phenomena; Chemistry; Daunorubicin; Depression, Chemical; DNA; Leukemia L1210; Leukemia P388; Mice | 1979 |
[Comparative characteristics of the antitumor and immunodepressive activity of carminomycin on the L-1210 experimental model].
Topics: Animals; Antibiotics, Antineoplastic; Carubicin; Daunorubicin; Dose-Response Relationship, Drug; Immunity; Immunization; Immunosuppressive Agents; Leukemia L1210; Mice; Mice, Inbred CBA; Mice, Inbred DBA; Neoplasm Transplantation; Time Factors | 1979 |
Cellular accumulation and disposition of aclacinomycin A.
Topics: Animals; Antibiotics, Antineoplastic; Cell Line; Cell Nucleus; Cytoplasm; Daunorubicin; Leukemia L1210; Leukemia P388; Leukemia, Experimental; Mice; Naphthacenes; Nucleic Acids | 1979 |
Comparative study in mice of the toxicity, pharmacology, and therapeutic activity of daunorubicin-DNA and doxorubicin-DNA complexes.
Topics: Animals; Bone Diseases; Daunorubicin; DNA; Doxorubicin; Female; Lethal Dose 50; Leukemia L1210; Mice; Tissue Distribution | 1979 |
The diffusion chamber technique as an in vivo assay in mice for the effectiveness of antitumor agents.
Topics: Animals; Antineoplastic Agents; Cell Transformation, Neoplastic; Cells, Cultured; Colony-Forming Units Assay; Daunorubicin; Diffusion; DNA; Female; Leukemia L1210; Mice; Mice, Inbred DBA | 1979 |
Biologic properties of three anthracyclines as a function of lipophilicity.
Topics: Animals; Antibiotics, Antineoplastic; Carubicin; Chemical Phenomena; Chemistry; Daunorubicin; Doxorubicin; Glycosides; In Vitro Techniques; Leukemia L1210; Lipids; Naphthacenes; Solubility; Temperature; Time Factors | 1979 |
Tetrahydropyranyl derivatives of daunomycin and adriamycin.
Topics: Animals; Antibiotics, Antineoplastic; Daunorubicin; Doxorubicin; Leukemia L1210; Mice | 1979 |
Baumycins, new antitumor antibiotics related to daunomycin.
Topics: Animals; Bacteria; Cells, Cultured; Chemical Phenomena; Chemistry; Daunorubicin; DNA, Neoplasm; Hydrolysis; In Vitro Techniques; Leukemia L1210; RNA, Neoplasm; Streptomyces | 1977 |
Cellular uptake and metabolism of daunorubicin as determined by high-performance liquid chromatography. Application to L1210 cells.
Topics: Animals; Cells, Cultured; Chromatography, High Pressure Liquid; Daunorubicin; Humans; Leukemia L1210; Mice | 1978 |
Antitumor activity of new anthracycline antibiotics, aclacinomycin-A and its analogs, and their toxicity.
Topics: Aclarubicin; Animals; Anthraquinones; Antibiotics, Antineoplastic; Cricetinae; Daunorubicin; Doxorubicin; Electrocardiography; Glycosides; Heart; Leukemia L1210; Leukemia, Experimental; Lymphoma, Non-Hodgkin; Male; Mesocricetus; Mice; Mice, Inbred Strains; Sarcoma 180; Sarcoma, Experimental; Streptomyces | 1977 |
Changes of activity of daunorubicin, adriamycin and stereoisomers following the introduction or removal of hydroxyl groups in the amino sugar moiety.
Topics: Animals; Binding Sites; Clone Cells; Daunorubicin; DNA; Doxorubicin; HeLa Cells; Leukemia L1210; Leukemia, Experimental; Mice; Stereoisomerism; Structure-Activity Relationship | 1977 |
Agglutination of leukemic cells and daunomycin entrapped erythrocytes with lectin in vitro and in vivo.
Topics: Animals; Daunorubicin; Erythrocyte Membrane; Erythrocytes; In Vitro Techniques; Lectins; Leukemia L1210; Mice; Plant Lectins; Triticum | 1978 |
Influence of continuous infusion of cytosine arabinoside on sequencing with daunorubicin in L1210 leukemia.
Topics: Animals; Cell Survival; Cytarabine; Daunorubicin; Leukemia L1210; Mice; Neoplasm Transplantation; Time Factors; Transplantation, Homologous | 1978 |
Effect of various substitutions in positions 1, 2, 3, and 4 of 4-demethoxydaunorubicin and 4-demethoxyadriamycin.
Topics: Animals; Antineoplastic Agents; Daunorubicin; Doxorubicin; HeLa Cells; Humans; Leukemia L1210; Leukemia, Experimental; Mice; Structure-Activity Relationship | 1978 |
Activity of anthracyclines against an adriamycin (NSC-123127)-resistant subline of P388 leukemia with special emphasis on cinerubin A (NSC-18334).
Topics: Animals; Antibiotics, Antineoplastic; Carubicin; Chemical Phenomena; Chemistry; Daunorubicin; Doxorubicin; Drug Resistance; Haplorhini; Leukemia L1210; Leukemia, Experimental; Lung Neoplasms; Male; Melanoma; Mice; Neoplasm Transplantation; Transplantation, Homologous | 1976 |
Concanavalin A as a carrier of daunomycin.
Topics: Animals; Carcinoma, Ehrlich Tumor; Cell Aggregation; Concanavalin A; Daunorubicin; Drug Combinations; Hydrocortisone; Leukemia L1210; Mice | 1977 |
[Comparative experimental study of the antileukemia activity of carminomycin and rubomycin].
Topics: Animals; Antibiotics, Antineoplastic; Carubicin; Daunorubicin; Drug Evaluation, Preclinical; Leukemia L1210; Leukemia, Experimental; Mice; Neoplasm Transplantation; Time Factors | 1977 |
Combination chemotherapy with 4'Demethylepipodophyllotoxin 9-(4,6-0-ethylidene-beta-D-glucopyranoside), VP 16-213 (NSC 141540) in L1210 leukemia.
Topics: Animals; Antineoplastic Agents; Carmustine; Cyclophosphamide; Cytarabine; Dactinomycin; Daunorubicin; Drug Therapy, Combination; Etoposide; Female; Fluorouracil; Leukemia L1210; Male; Mercaptopurine; Methotrexate; Mice; Mice, Inbred DBA; Podophyllotoxin; Vincristine | 1976 |
A characterization of the immunosuppressive activity of adriamycin and daunomycin on humoral antibody production and tumor allograft rejection.
Topics: Animals; Antibody Formation; Antibody-Producing Cells; Bone Marrow; Clone Cells; Daunorubicin; DNA, Neoplasm; Doxorubicin; Female; Graft Rejection; Hematopoietic Stem Cells; Immunization, Secondary; Immunosuppressive Agents; Leukemia L1210; Mice; Mice, Inbred C3H; Neoplasm Transplantation; Polysaccharides, Bacterial; Transplantation, Homologous | 1976 |
Alterations in adriamycin efficacy by phenobarbital.
Topics: Alcohol Oxidoreductases; Animals; Daunorubicin; Doxorubicin; Leukemia L1210; Liver; Mice; Mice, Inbred BALB C; Microsomes, Liver; Phenobarbital | 1976 |
The effects of adriamycin and daunomycin on antitumoral immune effector mechanisms in an allogeneic system.
Topics: Animals; Antibodies, Neoplasm; Antibody Formation; Ascitic Fluid; Cytotoxicity Tests, Immunologic; Daunorubicin; Doxorubicin; Female; Graft Rejection; Immunity, Cellular; Leukemia L1210; Mice; Mice, Inbred C3H; Transplantation, Homologous | 1976 |
Synthesis and antitumor activity of 4'-deoxydaunorubicin and 4'-deoxyadriamycin.
Topics: Animals; Antineoplastic Agents; Daunorubicin; Doxorubicin; Leukemia L1210; Mice; Sarcoma 180 | 1976 |
Synthesis and antitumor activity of 4-demethoxydaunorubicin, 4-demethoxy-7,9-diepidaunorubicin, and their beta anomers.
Topics: Animals; Daunorubicin; Dose-Response Relationship, Drug; Leukemia L1210; Mice; Neoplasms, Experimental; Sarcoma 180 | 1976 |
N-trifluoroacetyladriamycin-14-valerate, an analog with greater experimental antitumor activity and less toxicity than adriamycin.
Topics: Animals; Cell Division; Cell Line; Cell-Free System; Daunorubicin; Doxorubicin; Leukemia L1210; Leukemia, Experimental; Leukemia, Lymphoid; Mice; Mice, Inbred C57BL; Mice, Inbred DBA | 1975 |
Uptake of adriamycin and daunomycin in L1210 and human leukemia cells: a comparative study.
Topics: Animals; Daunorubicin; Doxorubicin; Humans; In Vitro Techniques; Leukemia; Leukemia L1210; Mice; Temperature; Time Factors | 1976 |
Effects of adriamycin and daunomycin on spleen cell populations in normal and tumor allografted mice.
Topics: Animals; Antilymphocyte Serum; Daunorubicin; Doxorubicin; Female; Leukemia L1210; Mice; Mice, Inbred C3H; Spleen; T-Lymphocytes; Transplantation, Homologous | 1976 |
Pharmacological and therapeutic efficacy of daunomycin:DNA complex in mice.
Topics: Animals; Chick Embryo; Daunorubicin; DNA; Ethanol; Fluorescence; Half-Life; Hydrochloric Acid; Leukemia L1210; Liver; Mice; Mice, Inbred DBA; Mice, Inbred ICR; Spleen | 1975 |
Effect of 3-[4-amino-2-methyl-5-pyrimidinyl)ethyl[-1(2-chloroethyl)-1-nitrosourea hydrochloride on lymphoid leukemia L-1210.
Topics: Administration, Oral; Animals; Carbazilquinone; Cyclophosphamide; Daunorubicin; Dose-Response Relationship, Drug; Female; Injections, Intraperitoneal; Injections, Intravenous; Leukemia L1210; Lomustine; Male; Methotrexate; Mice; Mitomycins; Nitrogen Mustard Compounds; Nitrosourea Compounds; Time Factors; Triaziquone | 1975 |
Potentiation of actinomycin D or adriamycin antitumor activity with DNA.
Topics: Animals; Dactinomycin; Daunorubicin; DNA; Doxorubicin; Drug Synergism; Leukemia L1210; Leukemia, Experimental; Leukemia, Lymphoid; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Neoplasms, Experimental | 1976 |
Anthracycline metabolites from baumycin-producing Streptomyces sp. D788. I. Isolation of antibiotic-blocked mutants and their characterization.
Topics: Animals; Antibiotics, Antineoplastic; Chromatography, High Pressure Liquid; Daunorubicin; Leukemia L1210; Mice; Mutation; Streptomyces; Tumor Cells, Cultured | 1992 |
Production of new anthracycline antibiotics 1-hydroxy-oxaunomycin and 6-deoxyoxaunomycin by limited biosynthetic conversion using a daunorubicin-negative mutant.
Topics: Animals; Anthracyclines; Antibiotics, Antineoplastic; Carubicin; Chromatography, High Pressure Liquid; Chromatography, Thin Layer; Daunorubicin; DNA Replication; Drug Screening Assays, Antitumor; Leukemia L1210; Magnetic Resonance Spectroscopy; Mice; Microbiological Techniques; Mutation; Naphthacenes; Streptomyces; Tumor Cells, Cultured | 1992 |
Production of new anthracycline antibiotics by microbial 4-O-methylation using a specific daunorubicin-negative mutant.
Topics: Animals; Anthracyclines; Antibiotics, Antineoplastic; Biotransformation; Daunorubicin; DNA Replication; DNA, Neoplasm; Drug Resistance, Microbial; Drug Screening Assays, Antitumor; Leukemia L1210; Methylation; Mice; Streptomyces; Tumor Cells, Cultured | 1992 |
In vitro interaction of lithotripter shock waves and cytotoxic drugs.
Topics: Aclarubicin; Animals; Antineoplastic Agents; Cell Survival; Cisplatin; Daunorubicin; Dose-Response Relationship, Drug; Doxorubicin; Leukemia L1210; Lithotripsy; Mice; Tumor Cells, Cultured | 1992 |
Pharmacological and physicochemical properties of a new anthracycline with potent antileukemic activity.
Topics: Animals; Antibiotics, Antineoplastic; Cell Division; Daunorubicin; DNA Topoisomerases, Type II; G2 Phase; Humans; Leukemia L1210; Leukemia, Experimental; Leukemia, Myeloid; Mice; Mitosis; Oxidation-Reduction | 1991 |
Distribution of topoisomerase II cleavage sites in simian virus 40 DNA and the effects of drugs.
Topics: Amsacrine; Animals; Base Sequence; Daunorubicin; DNA Damage; DNA Replication; DNA Topoisomerases, Type II; DNA, Viral; Ellipticines; Genome, Viral; Kinetics; Leukemia L1210; Mice; Molecular Sequence Data; Restriction Mapping; Simian virus 40; Substrate Specificity; Teniposide | 1991 |
The synthesis, stability and biological activity of bis-intercalating bis-daunomycin hydrazones.
Topics: Animals; Antineoplastic Agents; Daunorubicin; Humans; Hydrazones; Intercalating Agents; Leukemia L1210; Mice; Molecular Conformation; Tumor Cells, Cultured | 1990 |
[Rubomycins M and N--new anthracycline antibiotics].
Topics: Animals; Burkitt Lymphoma; Cell Division; Daunorubicin; Humans; Leukemia L1210; Leukemia-Lymphoma, Adult T-Cell; Magnetic Resonance Spectroscopy; Mice; Streptomyces; Tumor Cells, Cultured | 1991 |
[Experimental combination chemotherapy of YNK01, a novel analog of cytarabine, with other antitumor agents].
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Arabinonucleotides; Cisplatin; Cytidine Monophosphate; Cytosine Nucleotides; Daunorubicin; Doxorubicin; Drug Synergism; Leukemia L1210; Leukemia P388; Leukemia, Experimental; Mercaptopurine; Mice; Mice, Inbred DBA; Mitomycin; Mitomycins; Vincristine | 1990 |
[Antitumor activities of orally administered 7-con-0-methylnogarol (TUT-7)].
Topics: Administration, Oral; Animals; Antineoplastic Agents; Colonic Neoplasms; Daunorubicin; Doxorubicin; Humans; Leukemia L1210; Leukemia P388; Leukemia, Experimental; Lung Neoplasms; Menogaril; Mice; Nogalamycin; Rats; Sarcoma, Yoshida | 1990 |
Menogaril, an anthracycline compound with a novel mechanism of action: cellular pharmacology.
Topics: Animals; Antineoplastic Agents; Daunorubicin; DNA Damage; DNA, Neoplasm; Doxorubicin; Leukemia L1210; Menogaril; Microtubule Proteins; Neoplasm Proteins; Nogalamycin; Polyphosphates; RNA, Neoplasm; Tubulin | 1990 |
Anthracycline antibiotics with high liposome entrapment: structural features and biological activity.
Topics: Animals; Antibiotics, Antineoplastic; Daunorubicin; Doxorubicin; Drug Carriers; Drug Design; Drug Stability; Leukemia L1210; Liposomes; Lymphoma, Large B-Cell, Diffuse; Mice; Mice, Inbred Strains; Sarcoma, Experimental; Structure-Activity Relationship | 1990 |
Synthetic anthracyclines: regiospecific total synthesis of D-ring thiophene analogues of daunomycin.
Topics: Animals; Antibiotics, Antineoplastic; Chemical Phenomena; Chemistry; Daunorubicin; Leukemia L1210; Thiophenes; Tumor Cells, Cultured | 1990 |
Induced multidrug resistance in murine leukemia L1210 and associated changes in a surface-membrane glycoprotein.
Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood Proteins; Cyclophosphamide; Cytarabine; Daunorubicin; Doxorubicin; Drug Resistance; Female; Immunoblotting; Leukemia L1210; Membrane Glycoproteins; Mice; Phenotype | 1989 |
Synthesis and antitumor activity of new anthracyclines.
Topics: Animals; Anthracyclines; Antibiotics, Antineoplastic; Chemical Phenomena; Chemistry; Daunorubicin; Drug Evaluation, Preclinical; Leukemia L1210; Mice; Tumor Cells, Cultured | 1989 |
Syntheses and antitumor activities of 7-O-(3-amino-2,3,6-trideoxy-2-fluoro-alpha-L-talopyranosyl)daunomvcinone and -adriamycinone.
Topics: Animals; Cell Division; Daunorubicin; Doxorubicin; Leukemia L1210; Mice; Tumor Cells, Cultured | 1989 |
Syntheses and antitumor activities of 7-O-(6-deoxy-2-O-methyl-alpha-L-talopyranosyl)-daunomycinone and -adriamycinone.
Topics: Animals; Daunorubicin; Doxorubicin; Leukemia L1210; Mice | 1989 |
Structural requirements for anthracycline-induced cardiotoxicity and antitumor effects.
Topics: Animals; Cell Division; Cells, Cultured; Daunorubicin; Doxorubicin; Heart; Lethal Dose 50; Leukemia L1210; Mice; Rats; Rats, Inbred Strains; Structure-Activity Relationship | 1989 |
Effects of 7-R-O-methylnogarol (menogaril) on L1210 cell progression in vitro and in vivo.
Topics: Animals; Antineoplastic Agents; Cell Cycle; Cell Line; Daunorubicin; DNA, Neoplasm; Leukemia L1210; Male; Menogaril; Mice; Mice, Inbred Strains; Nogalamycin | 1986 |
Inhibition of thymidylate synthase in intact L1210 cells by ara-C, daunomycin, hydroxyurea and 3,4-dihydroxybenzylamine.
Topics: Animals; Cytarabine; Daunorubicin; Deoxyuridine; DNA; Dopamine; Floxuridine; Hydroxyurea; Kinetics; Leukemia L1210; Methotrexate; Thymidylate Synthase | 1987 |
Synergy between low-dose chemotherapy and immunotherapy in mouse L1210 leukemia.
Topics: Animals; Bacterial Vaccines; Combined Modality Therapy; Corynebacterium; Daunorubicin; Glutaral; Immunization; Leukemia L1210; Male; Mice; Mice, Inbred Strains; Mitomycins; Spleen; Tetanus Toxin | 1987 |
Antitumour activity of new semi-synthetic anthracyclines containing fluorotalopyranose.
Topics: Animals; Daunorubicin; Doxorubicin; Leukemia L1210; Mice | 1988 |
Antitumor activity of new N-substituted daunorubicin derivatives.
Topics: Animals; Antibiotics, Antineoplastic; Cells, Cultured; Daunorubicin; Leukemia L1210; Mice; Saccharomyces cerevisiae | 1987 |
Synthesis and antileukemic activity of N-enamine derivatives of daunorubicin, 5-iminodaunorubicin, and doxorubicin.
Topics: Animals; Antibiotics, Antineoplastic; Daunorubicin; Doxorubicin; Drug Screening Assays, Antitumor; Injections, Intraperitoneal; Leukemia L1210; Leukemia P388; Mice; Structure-Activity Relationship | 1988 |
Anticancer agents coupled to N-(2-hydroxypropyl)methacrylamide copolymers. II. Evaluation of daunomycin conjugates in vivo against L1210 leukaemia.
Topics: Acrylamides; Animals; Body Weight; Daunorubicin; Drug Carriers; Leukemia L1210; Male; Mice; Mice, Inbred DBA; Time Factors; Tissue Distribution | 1988 |
Synthesis of antitumor-active 7-O-(2,6-dideoxy-2-fluoro-alpha-L-talopyranosyl)-daunomycinone and -adriamycinone.
Topics: Animals; Antibiotics, Antineoplastic; Daunorubicin; Doxorubicin; Indicators and Reagents; Leukemia L1210; Magnetic Resonance Spectroscopy; Mice; Optical Rotation; Structure-Activity Relationship | 1987 |
Verapamil potentiation of VP-16-213 in acute lymphatic leukemia and reversal of pleiotropic drug resistance.
Topics: Animals; Antineoplastic Agents; Cell Survival; Cells, Cultured; Daunorubicin; Dose-Response Relationship, Drug; Drug Resistance; Drug Synergism; Etoposide; Humans; Leukemia L1210; Leukemia P388; Leukemia, Experimental; Leukemia, Lymphoid; Mice; Podophyllotoxin; Verapamil; Vincristine | 1986 |
Anticancer agents coupled to N-(2-hydroxypropyl)methacrylamide copolymers. I. Evaluation of daunomycin and puromycin conjugates in vitro.
Topics: Acrylates; Animals; Cell Division; Cell Survival; Chemical Phenomena; Chemistry; Daunorubicin; Dose-Response Relationship, Drug; Humans; Leukemia; Leukemia L1210; Leukemia, Lymphoid; Methacrylates; Mice; Pharmaceutical Vehicles; Puromycin | 1987 |
Interaction of aclarubicin with DNA as compared with daunorubicin and doxorubicin.
Topics: Aclarubicin; Animals; Antibiotics, Antineoplastic; Binding Sites; Cattle; Cells, Cultured; Daunorubicin; DNA; Doxorubicin; Drug Interactions; Female; Leukemia L1210; Mice; Naphthacenes | 1986 |
[Models of preclinical studies of anthracyclines].
Topics: Animals; Antibiotics, Antineoplastic; Daunorubicin; Doxorubicin; Drug Evaluation, Preclinical; Humans; Leukemia L1210; Leukemia P388; Leukemia, Experimental; Mice | 1987 |
A new anthracycline metabolite D788-1 (10-carboxy-13-deoxocarminomycin) in daunorubicin beer.
Topics: Animals; Antibiotics, Antineoplastic; Carubicin; Chemical Phenomena; Chemistry; Daunorubicin; Leukemia L1210; Mice | 1986 |
Three alkaloids as selective destroyers of cancer cells in mice. Synergy with classic anticancer drugs.
Topics: Alkaloids; Animals; Antineoplastic Combined Chemotherapy Protocols; Daunorubicin; Drug Synergism; Fluorouracil; Leukemia L1210; Lomustine; Mice; Neoplasms, Experimental; Secologanin Tryptamine Alkaloids | 1986 |
Intensely potent anthracycline antibiotic oxaunomycin produced by a blocked mutant of the daunorubicin-producing microorganism.
Topics: Animals; Anthracyclines; Antibiotics, Antineoplastic; Chemical Phenomena; Chemistry; Daunorubicin; Leukemia L1210; Mice; Mutation; Naphthacenes; Streptomyces | 1986 |
New N-amino acid derivatives of daunorubicin.
Topics: Animals; Antibiotics, Antineoplastic; Chemical Phenomena; Chemistry; Daunorubicin; Leukemia L1210; Leukemia P388; Rats | 1986 |
Polylysine-drug conjugates.
Topics: 6-Aminonicotinamide; Animals; Antibiotics, Antineoplastic; Carcinoma, Ehrlich Tumor; Cell Division; Cell Survival; Daunorubicin; Doxorubicin; HeLa Cells; Humans; Indicators and Reagents; Kinetics; Leukemia L1210; Methods; Methotrexate; Mice; Naphthacenes; Polylysine; Structure-Activity Relationship | 1985 |
Formation of DNA-adducts and induction of DNA-crosslinks and chromosomal aberrations by the new potent anthracycline antitumor antibiotics: morpholinodaunomycin, cyanomorpholinodaunomycin and cyanomorpholinoadriamycin.
Topics: Animals; Antibiotics, Antineoplastic; Cells, Cultured; Chemical Phenomena; Chemistry; Chromosome Aberrations; Daunorubicin; DNA; DNA Repair; Doxorubicin; Leukemia L1210; Liver; Rats | 1985 |
Synthesis and antitumor activity of 3'-C-methyl-daunorubicin.
Topics: Animals; Antineoplastic Agents; Daunorubicin; Doxorubicin; Drug Resistance; Leukemia L1210; Leukemia P388; Magnetic Resonance Spectroscopy; Mice; Tumor Stem Cell Assay | 1985 |
Cell surface effects of adriamycin and carminomycin immobilized on cross-linked polyvinyl alcohol.
Topics: Animals; Carubicin; Cell Survival; Cells, Cultured; Daunorubicin; Dose-Response Relationship, Drug; Doxorubicin; Leukemia L1210; Mice; Polyvinyl Alcohol | 1985 |
Effects of deoxyribonucleic acid-reactive drugs on ribonucleic acid synthesis in leukemia L1210 cells.
Topics: Acridines; Acrylamides; Alkaloids; Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Benzazepines; Camptothecin; Carbazoles; Carbon Isotopes; Cell Nucleolus; Cell Nucleus; Centrifugation, Density Gradient; Dactinomycin; Daunorubicin; Deoxyadenosines; DNA, Neoplasm; Ethidium; Leukemia L1210; Mechlorethamine; Methionine; Phenanthridines; Pyridines; Pyrroles; RNA, Neoplasm; Tritium; Uridine | 1972 |
[Ethidium bromhydrate effect on L 1210 mouse leukemia].
Topics: Animals; Cyclophosphamide; Dactinomycin; Daunorubicin; Doxorubicin; Ellipticines; Ethidium; Female; Fluorouracil; Leukemia L1210; Mice | 1974 |
Daunomycin pharmacological activity at the cellular level.
Topics: Animals; Carcinoma, Ehrlich Tumor; Daunorubicin; DNA, Neoplasm; In Vitro Techniques; Leukemia L1210; Leukemia Virus, Murine; Leukemia, Experimental; Liver; Mice; RNA, Neoplasm | 1967 |
[Antitumor activity of adriamycin].
Topics: Administration, Oral; Animals; Carcinoma, Ehrlich Tumor; Carcinoma, Hepatocellular; Cyclophosphamide; Daunorubicin; Doxorubicin; Injections, Intraperitoneal; Injections, Intravenous; Injections, Subcutaneous; Lethal Dose 50; Leukemia L1210; Liver Neoplasms; Lymphoma; Male; Mice; Mice, Inbred C3H; Mice, Inbred Strains; Mitomycins; Neoplasms, Experimental; Rats; Sarcoma 180; Sarcoma, Yoshida | 1972 |
Adriamycin (NSC-123127) and its analogs.
Topics: Animals; Daunorubicin; DNA; DNA, Neoplasm; Doxorubicin; Humans; Leukemia L1210; Mice; Molecular Conformation; Neoplasms; Structure-Activity Relationship | 1974 |
[Possibility of utilizing lymphatic leukemia L1210 as a first screening model in the primary selection of new antitumor antibiotics].
Topics: Administration, Oral; Aminoglycosides; Animals; Antibiotics, Antineoplastic; Dactinomycin; Daunorubicin; Drug Evaluation, Preclinical; Hybridization, Genetic; Injections, Intravenous; Injections, Subcutaneous; Leukemia L1210; Methotrexate; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Naphthacenes; Neoplasm Transplantation; Olivomycins; Streptonigrin; Time Factors | 1974 |
X-ray repair replication in L1210 leukemia cells.
Topics: Animals; Bromodeoxyuridine; Cells, Cultured; Cytarabine; Daunorubicin; DNA Repair; Dose-Response Relationship, Drug; Doxorubicin; Kinetics; Leukemia L1210; Mice; Radiation Dosage; Radiation Injuries, Experimental; Thymidine; Tritium | 1974 |
DCMP therapy in acute leukemia--the experimental and clinical study.
Topics: Acute Disease; Adult; Animals; Child; Cytarabine; Daunorubicin; Drug Therapy, Combination; Humans; Leukemia; Leukemia L1210; Mercaptopurine; Prednisolone; Time Factors | 1974 |
Comparative chemotherapy of AKR lymphoma and human hematological neoplasia.
Topics: Animals; Antineoplastic Agents; Biological Assay; Carmustine; Cyclohexanes; Cyclophosphamide; Cytarabine; Daunorubicin; Disease Models, Animal; Drug Therapy, Combination; Evaluation Studies as Topic; Female; Fluorouracil; Hodgkin Disease; Humans; Leukemia; Leukemia L1210; Leukemia, Experimental; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Lymphoma; Male; Mechlorethamine; Melphalan; Mice; Mice, Inbred AKR; Multiple Myeloma; Nitrosourea Compounds; Prednisone; Remission, Spontaneous; Vinblastine; Vincristine | 1974 |
A fluorometric assay for daunomycin and adriamycin in animal tissues.
Topics: Animals; Chromatography, Thin Layer; Daunorubicin; DNA; Doxorubicin; Female; Fluorometry; Intestines; Kidney; Leukemia L1210; Liver; Methods; Mice; Myocardium; Pentanols; Rats; Silver Nitrate; Solubility; Spleen; Thymus Gland | 1973 |
Adriamycin and daunorubicin: a comparison of antitumor activities and tissue uptake in mice following immunosuppression.
Topics: Animals; Cyclophosphamide; Daunorubicin; Doxorubicin; Female; Fluorometry; Immunity; Immunosuppressive Agents; Leukemia L1210; Leukemia, Experimental; Leukemia, Lymphoid; Liver; Mice; Mice, Inbred DBA; Neoplasm Transplantation; Radiation Effects; Spleen; Thymus Gland; Transplantation, Homologous | 1973 |
Schedule-dependent synergism for the combination of 1-beta-D-arabinofuranosylcytosine and daunorubicin.
Topics: Animals; Cell Division; Cell Survival; Cytarabine; Daunorubicin; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Female; Leukemia L1210; Male; Mice; Mice, Inbred C3H; Mice, Inbred DBA; Time Factors | 1974 |
Enhancement of antitumor effectiveness of ICRF-159 (NSC-129943) against early L1210 leukemia by combination with cis-diamminedichloroplatinum (NSC-119875) or daunomycin (NSC-82151).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Chemical Phenomena; Chemistry; Cisplatin; Daunorubicin; Dose-Response Relationship, Drug; Doxorubicin; Drug Synergism; Drug Therapy, Combination; Injections, Intraperitoneal; Injections, Intravenous; Injections, Subcutaneous; Leukemia L1210; Mice; Piperazines; Propane | 1974 |
Total synthesis of the antitumor antibiotic danuorubicin. Coupling of the sugar and aglycone.
Topics: Animals; Cells, Cultured; Chromatography, Thin Layer; Circular Dichroism; Daunorubicin; Depression, Chemical; DNA, Neoplasm; Leukemia L1210; Magnetic Resonance Spectroscopy; Methods; Mice; RNA, Neoplasm; Spectrophotometry, Ultraviolet | 1974 |
Structure-antitumor activity relationships among quinone derivatives.
Topics: Animals; Anthraquinones; Antineoplastic Agents; Azirines; Bridged-Ring Compounds; Carcinoma 256, Walker; Daunorubicin; Drug Evaluation, Preclinical; Heterocyclic Compounds; L-Lactate Dehydrogenase; Leukemia L1210; Mice; Mitomycins; Naphthoquinones; Neoplasms, Experimental; Quinones; Sarcoma 180; Streptonigrin; Structure-Activity Relationship | 1974 |
Observations on toxicity and clinical trials with daunomycin.
Topics: Adult; Animals; Child; Daunorubicin; Dogs; Haplorhini; Humans; Injections, Intravenous; Leukemia; Leukemia L1210; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Mice; Neoplasms; Neuroblastoma | 1967 |
Inhibition of DNA and RNA metabolism by daunorubicin and adriamycin in L1210 mouse leukemia.
Topics: Amino Sugars; Animals; Antibiotics, Antineoplastic; Carbon Isotopes; Cells, Cultured; Daunorubicin; DNA, Neoplasm; Glycosides; Leukemia L1210; Mice; Naphthacenes; RNA, Neoplasm; Thymidine; Time Factors; Tritium; Uridine | 1972 |
Antitumor activity of some derivatives of daunorubicin at the amino and methyl ketone functions.
Topics: Acylation; Amines; Animals; Antibiotics, Antineoplastic; Chromatography, Thin Layer; Daunorubicin; Injections, Intraperitoneal; Ketones; Leukemia L1210; Magnetic Resonance Spectroscopy; Mice; Optical Rotation; Structure-Activity Relationship | 1972 |
Comparative biochemical studies of adriamycin and daunomycin in leukemic cells.
Topics: Animals; Antibiotics, Antineoplastic; Daunorubicin; Depression, Chemical; DNA Nucleotidyltransferases; DNA, Neoplasm; Female; In Vitro Techniques; Leukemia L1210; Mice; Mice, Inbred Strains; Neoplasm Proteins; RNA, Neoplasm; Thymidine; Tritium; Uridine; Valine | 1972 |
Kinetic evaluation of the effect of actinomycin D, daunomycin, and mitomycin C on proliferating cultured leukemia L 1210 cells.
Topics: Animals; Cell Division; Dactinomycin; Daunorubicin; Kinetics; Leukemia L1210; Mitomycins; Streptomyces | 1971 |
The treatment of acute lymphocytic leukemia.
Topics: Animals; Antineoplastic Agents; Asparaginase; Blood Platelets; Bone Marrow Cells; Cyclophosphamide; Cytarabine; Daunorubicin; Disease Models, Animal; Drug Synergism; Hemorrhage; Humans; Infections; Leukemia L1210; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Mercaptopurine; Methotrexate; Mice; Prednisone; Prognosis; Thrombocytopenia; Vincristine | 1970 |
[Chemotherapy of L1210 leukemia: comparison of 7 drugs given either continuously for 20 days, or in a single massive dose, early or late].
Topics: Animals; Cyclophosphamide; Daunorubicin; Leucovorin; Leukemia L1210; Life Expectancy; Mercaptopurine; Methotrexate; Methylprednisolone; Mice; Statistics as Topic; Vinblastine; Vincristine | 1968 |
Comparison of the antileukemic effect in mice of adriamycin (NSC-123127) with daunomycin (NSC-82151).
Topics: Animals; Antibiotics, Antineoplastic; Daunorubicin; Leukemia L1210; Male; Mice | 1970 |
Implications of biochemical, cytokinetic, pharmacologic, and toxicologic relationships in the design of optimal therapeutic schedules.
Topics: Animals; Antineoplastic Agents; Cyclophosphamide; Cytarabine; Dactinomycin; Daunorubicin; Disease Models, Animal; DNA, Neoplasm; Fluorouracil; Half-Life; Hydroxyurea; In Vitro Techniques; Kinetics; Leukemia L1210; Mercaptopurine; Methotrexate; Mice; Mitosis; Nitrosourea Compounds; Thiosemicarbazones | 1970 |